Literature DB >> 25436277

Prognostic significance of hypokalemia in hepatic encephalopathy.

Vinaya Gaduputi, Chaitanya Chandrala, Naeem Abbas, Hassan Tariq, Sridhar Chilimuri, Bhavna Balar.   

Abstract

BACKGROUND/AIMS: The aim of this study was to investigate whether hypokalemia prognosticates outcomes in hepatic encephalopathy. We also examined other potential prognostic variables such as serum pH, systemic vascular resistance (SVR) and serum ammonia levels.
METHODOLOGY: Patients with cirrhosis who were admitted for overt hepatic encephalopathy were included in the study and divided into two groups: Group-I consisted of patients with serum Potassium level < 4.0 mEq/L and Group-II consisted of patients with serum Potassium level > 4.0 mEq/L. We collected the baseline demographic data for both the groups including age, gender, ethnicity and calculated the Model for End Stage Liver Disease scores for both the groups at the time of admission. We analyzed the correlation between serum potassium levels and outcome variables including 30- day mortality rate, length of Intensive Care Unit (ICU)/ hospital stay, mechanical ventilation rate and 30-day readmission rate.
RESULTS: A total of 447 patients with diagnosis of cirrhosis were admitted to the hospital with overt hepatic encephalopathy between January 2008 and December 2012. 157 patients with low Potassium level (< 4.0 mEq/L) were included in Group-I while 290 patients with normal Potassium level (> 4.0 mEq/L) and were included in Group-II. Total length of stay in the hospital (P Value= 0.0001) and ICU length of stay (P Value= 0.0003) were significantly longer among the patients with serum potassium level of <4mEq/L.
CONCLUSIONS: We observed statistically significant correlation between serum potassium level and length of stay in hospital and ICU.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25436277

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Hypokalemia is a biochemical signal of poor prognosis for acute paraquat poisoning within 4 hours.

Authors:  Zun-Qi Liu; Hai-Shi Wang; Yan Gu
Journal:  Intern Emerg Med       Date:  2016-07-09       Impact factor: 3.397

Review 2.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

3.  Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.

Authors:  Jejo D Koola; Sam B Ho; Aize Cao; Guanhua Chen; Amy M Perkins; Sharon E Davis; Michael E Matheny
Journal:  Dig Dis Sci       Date:  2019-09-17       Impact factor: 3.199

4.  Nationwide analysis of incidence and predictors of 30-day readmissions in patients with decompensated cirrhosis.

Authors:  Mahesh Gajendran; Chandraprakash Umapathy; Abhilash Perisetti; Priyadarshini Loganathan; Alok Dwivedi; Luis A Alvarado; Marc J Zuckerman; Hemant Goyal; Sherif Elhanafi
Journal:  Frontline Gastroenterol       Date:  2021-07-02

5.  Hospital Readmissions in Patients with Cirrhosis: A Systematic Review.

Authors:  Eric S Orman; Marwan Ghabril; Thomas W Emmett; Naga Chalasani
Journal:  J Hosp Med       Date:  2018-04-25       Impact factor: 2.960

6.  Serum potassium levels and prognosis in HBV-associated decompensated cirrhosis.

Authors:  JianJiang Huang; Ming Cai; Xia He
Journal:  J Clin Lab Anal       Date:  2021-05-05       Impact factor: 2.352

7.  Unexpected clinical outcomes following the implementation of a standardised order set for hepatic encephalopathy.

Authors:  Mandip Kc; Andrew P J Olson; Qi Wang; Nicholas Lim
Journal:  BMJ Open Gastroenterol       Date:  2021-04

8.  CLIF-SOFA score and SIRS are independent prognostic factors in patients with hepatic encephalopathy due to alcoholic liver cirrhosis.

Authors:  Jin Hee Jeong; In Sung Park; Dong Hoon Kim; Seong Chun Kim; Changwoo Kang; Soo Hoon Lee; Tae Yun Kim; Sang Bong Lee
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.